Literature DB >> 11574736

Changes in heart rate variability in chronic uremic patients during ultrafiltration and hemodialysis.

F Galetta1, A Cupisti, F Franzoni, E Morelli, R Caprioli, P Rindi, G Barsotti.   

Abstract

BACKGROUND: The analysis of heart rate variability (HRV) is a useful tool to evaluate cardiac autonomic modulation, which is frequently impaired in chronic uremia. AIMS: The aim of this study was to evaluate HRV in chronic uremics and to separately investigate the acute changes induced by volume depletion and solute removal during a hemodialysis session.
METHODS: Fourteen uremic patients (8 males and 6 females, aged 50 +/- 15 years) on maintenance hemodialysis and 14 sex- and age-matched healthy controls were studied. Both groups underwent ambulatory electrocardiogram monitoring to evaluate the HRV time and frequency domain indices. The hemodialysis session was performed by 1 h of high-rate isolated ultrafiltration followed by 3 h of bicarbonate diffusive procedure.
RESULTS: In uremic patients, the overall variability in the frequency [low-frequency power (LF): 505 +/- 473, vs. 1,446 +/- 654; high-frequency power (HF): 133 +/- 162 vs. 512 +/- 417; p < 0.001] and time domain indices (standard deviation of normal R-R intervals: 101.9 +/- 33.3 vs. 181.7 +/- 44.1 ms; p < 0.001) was markedly reduced compared to controls, whereas mean heart rate (83 +/- 12.4 vs. 60.9 +/- 8.8 bpm; p < 0.001) and LF/HF ratio (5.8 +/- 3.5 vs. 2.2 +/- 0.8; p < 0.001) were increased. Isolated ultrafiltration produced a marked further decrease in HRV indices, but the subsequent diffusive hemodialysis procedure, with a low ultrafiltration rate, made HRV increase again.
CONCLUSIONS: Chronic uremics showed abnormal autonomic modulation with sympathetic-vagal imbalance. The unbalanced hypersympathetic response to body fluid depletion is related to the ultrafiltration rate. Low interdialytic weight gain and a low ultrafiltration rate, associated with adequate hemodialysis, should be the preferable strategy for uremic patients with autonomic dysfunction. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11574736     DOI: 10.1159/000046970

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  5 in total

1.  Correction of hyperphosphatemia suppresses cardiac remodeling in uremic rats.

Authors:  Ai Yamazaki-Nakazawa; Masahide Mizobuchi; Hiroaki Ogata; Chiaki Kumata; Fumiko Kondo; Naoko Ono; Fumihiko Koiwa; Susumu Uda; Eriko Kinugasa; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2013-06-06       Impact factor: 2.801

Review 2.  Phosphate and cardiovascular disease.

Authors:  Jessica Kendrick; Bryan Kestenbaum; Michel Chonchol
Journal:  Adv Chronic Kidney Dis       Date:  2011-03       Impact factor: 3.620

3.  Changes in the QT intervals, QT dispersion, and amplitude of T waves after hemodialysis.

Authors:  Abdenasser Drighil; John E Madias; Meryem Benjelloun; Hanane Kamoum; Ahmed Bennis; Leila Azzouzi; Asma Yazidi; Benyouness Ramdani
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-04       Impact factor: 1.468

4.  Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study.

Authors:  Rulan S Parekh; Lucy A Meoni; Bernard G Jaar; Stephen M Sozio; Tariq Shafi; Gordon F Tomaselli; Joao A Lima; Larisa G Tereshchenko; Michelle M Estrella; W H Linda Kao
Journal:  BMC Nephrol       Date:  2015-04-24       Impact factor: 2.388

5.  CARDIAC DISORDER IN HEMODIALYSIS: BENEFITS OF CHINESE HERBS.

Authors:  ZhongQing Lü; Min Sun; ChunJie Hu; YanQing Tong
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.